A team of researchers has uncovered how cancer evades the immune system and spreads throughout the body and is investigating ways to disable this potentially harmful trait.
Understanding how cancer develops is necessary for designing efficient, individualised cancer medicines. Scientists have known for many years that certain types of gene mutations are the cause of cancer.
Designing efficient, individualised cancer medicines requires an understanding of how cancer develops. For many years, scientists have understood that certain kinds of gene mutations are the origin of cancer.
According to new research, a biomarker signature can predict how well kidney cancer patients will respond to immunotherapy before treatment even starts. This biomarker signature is made up of the number of immune cells in and around kidney tumours, the volume of dead cancer tissue, and mutat
A team from UNIGE has created a novel technique for testing various medications without using animals or the body of the patient. Organoids, which are tiny replicas of organs and tissues made from patients exposed to therapies, were used by the researchers
Despite advances in pancreatic cancer treatment, only around 9% of patients live beyond five years. Researchers have failed to identify genetic distinctions that explain why some patients live for a long time and others do not, so they have moved their focus to the gut microbiome.
Options for treatment are limited when cancer spreads to the brain. The majority of medications made to fight metastases either cannot penetrate the blood-brain barrier or are ineffective against brain metastases.
The University of Cincinnati's researchers have created a similar strategy for treating cancer, connecting cancer cells to potent radiation therapy with bacteria acting as the adaptor.
Women suffering from mental illness, neuropsychiatric disability, or substance addiction are less likely to undergo gynaecological screening tests for cervical cancer and are more than twice as likely to develop the disease.
According to a new multi-institutional translational study headed by Weill Cornell Medical experts, obesity may cause DNA damage in the breast tissue of women who have BRCA1 or BRCA2 mutations, potentially adding to breast cancer development in an already high-risk group.